{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:05:20Z","timestamp":1792209920328,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinejcf.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cardfail.2024.09.010","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T18:54:32Z","timestamp":1727549672000},"page":"813-820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Psychometric Performance of the Kansas City Cardiomyopathy Questionnaire-12 in Symptomatic Obstructive Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"31","author":[{"given":"ANDREW J.","family":"SAUER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHARLES F.","family":"SHERROD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KENSEY L.","family":"GOSCH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SUZANNE V.","family":"ARNOLD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MATTHEW","family":"REANEY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUE","family":"ZHONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JENNY","family":"LAM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KATHLEEN W.","family":"WYRWICH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOHN A.","family":"SPERTUS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2024.09.010_bib0001","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.jtcvs.2021.04.001","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"162","author":"Ommen","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0002","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0003","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0004","first-page":"3","article-title":"Idiopathic hypertrophic subaortic stenosis. 1, a description of the disease based upon an analysis of 64 patients","volume":"30","author":"Braunwald","year":"1964","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0005","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jchf.2022.03.002","article-title":"Validation of the Kansas City Cardiomyopathy Questionnaire in symptomatic obstructive hypertrophic cardiomyopathy","volume":"10","author":"Nassif","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0006","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/CIRCOUTCOMES.115.001958","article-title":"Development and validation of a short version of the Kansas City Cardiomyopathy Questionnaire","volume":"8","author":"Spertus","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0007","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.122.009677","article-title":"Evaluating the implementation of patient-reported outcomes in heart failure clinic: a qualitative assessment","volume":"16","author":"Brown-Johnson","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0008","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.007027","article-title":"Patient perspectives on the completion and use of patient-reported outcome surveys in routine clinical care for heart failure","volume":"13","author":"Mondesir","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0009","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.006853","article-title":"Study design and rationale of EXPLORER-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy","volume":"13","author":"Ho","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0010","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0011","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/hrt.2006.089656","article-title":"Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure","volume":"93","author":"Raphael","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0012","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1067\/mhl.2002.124554","article-title":"Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease","volume":"31","author":"Bennett","year":"2002","journal-title":"Heart Lung"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0013","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCHEARTFAILURE.114.002248","article-title":"Cardiopulmonary exercise testing and prognosis in hypertrophic cardiomyopathy","volume":"8","author":"Coats","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0014","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ahj.2011.09.027","article-title":"Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure","volume":"163","author":"Flynn","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/13696998.2021.2011301","article-title":"Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trial","volume":"25","author":"Xie","year":"2022","journal-title":"J Med Econ"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0016","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0017","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s41669-022-00340-8","article-title":"Longitudinal psychometric analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) using outcomes from the phase III EXPLORER-HCM trial","volume":"6","author":"Reaney","year":"2022","journal-title":"Pharmacoecon Open"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0018","series-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0019","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure","volume":"35","author":"Green","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0020","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jacc.2020.09.542","article-title":"Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC State-of-the-Art Review","volume":"76","author":"Spertus","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0021","series-title":"Statistical Power Analysis for Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0022","series-title":"Basic Statistics for the Health Sciences","author":"Kuzma","year":"1984"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0023","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0895-4356(92)90194-R","article-title":"Measuring health status: what are the necessary measurement properties?","volume":"45","author":"Guyatt","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0024","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2307\/2532051","article-title":"A concordance correlation coefficient to evaluate reproducibility","volume":"45","author":"Lin","year":"1989","journal-title":"Biometrics"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0025","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/S0140-6736(21)00763-7","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"397","author":"Spertus","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.010280","article-title":"Impact of patient-reported outcome measurement in heart failure clinic on clinician health status assessment and patient experience: a substudy of the PRO-HF Trial","volume":"16","author":"Sandhu","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0027","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jchf.2019.12.011","article-title":"Endpoints in heart failure drug development: history and future","volume":"8","author":"Fiuzat","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0028","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamacardio.2021.0372","article-title":"Comparison of New York Heart Association class and patient-reported outcomes for heart failure with reduced ejection fraction","volume":"6","author":"Greene","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0029","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.14319","article-title":"Comparison of patient self-reported health status with clinician-assigned New York Heart Association classification","volume":"3","author":"Tran","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0030","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCHEARTFAILURE.113.000359","article-title":"Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction","volume":"6","author":"Joseph","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2024.09.010_bib0031","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/CIRCHEARTFAILURE.112.970053","article-title":"Use of the Kansas City Cardiomyopathy Questionnaire for monitoring health status in patients with aortic stenosis","volume":"6","author":"Arnold","year":"2013","journal-title":"Circ Heart Fail"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916424004172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916424004172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T05:36:19Z","timestamp":1747114579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916424004172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1071916424004172"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2024.09.010","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Psychometric Performance of the Kansas City Cardiomyopathy Questionnaire-12 in Symptomatic Obstructive Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2024.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Bristol Myers Squibb. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}